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Abstract
Background: Scrapie and bovine spongiform encephalopathy (BSE) belongs to the group of animal transmissible
spongiform encephalopathy (TSE). BSE epidemic in the UK and elsewhere in Europe has been linked to the use
of bovine meat and bone meals (MBM) in the feeding of cattle. There is concern that pigs, poultry and fish bred
for human consumption and fed with infected MBM would eventually develop BSE or carry residual infectivity
without disease. Although there has been no evidence of infection in these species, experimental data on the
susceptibility to the BSE agent of farm animals other than sheep and cow are limited only to pigs and domestic
chicken. In the framework of a EU-granted project we have challenged two species of fish largely used in human
food consumption, rainbow trout (Oncorhynchus mykiss) and turbot (Scophthalmus maximus), with a mouse-
adapted TSE strain (scrapie 139A), to assess the risk related to oral consumption of TSE contaminated food. In
trout, we also checked the "in vitro" ability of the pathological isoform of the mouse prion protein (PrPSc) to cross
the intestinal epithelium when added to the mucosal side of everted intestine.
Results: Fish challenged with a large amount of scrapie mouse brain homogenate by either oral or parenteral
routes, showed the ability to clear the majority of infectivity load. None of the fish tissues taken at different time
points after oral or parenteral inoculation was able to provoke scrapie disease after intracerebral inoculation in
recipient mice. However, a few recipient mice were positive for PrPSc and spongiform lesions in the brain. We
also showed a specific binding of PrPSc to the mucosal side of fish intestine in the absence of an active uptake of
the prion protein through the intestinal wall.
Conclusion: These results indicate that scrapie 139A, and possibly BSE, is quickly removed from fish tissues
despite evidence of a prion like protein in fish and of a specific binding of PrPSc to the mucosal side of fish intestine.
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Transmissible spongiform encephalopathy (TSE) or prion
diseases are fatal human and animal neurological disor-
ders with a worldwide distribution. Human TSE diseases
include sporadic, genetic, iatrogenic and variant Creut-
zfeldt-Jakob disease (CJD), Gerstmann-Sträussler-
Scheinker disease and sporadic or familial fatal insomnia.
Animal counterparts are scrapie in sheep and goats,
bovine spongiform encephalopathy (BSE), transmissible
mink encephalopathy, and chronic wasting disease of
mule deer and elk. There are strong evidences that among
human TSE diseases only variant CJD is caused by the
consumption of BSE-contaminated meat products [1,2].
The critical pathogenetic event in TSE diseases is the con-
formational change of the physiological host prion pro-
tein (PrPc) into an insoluble form (PrPSc) able to provoke
the pathognomonic brain lesions and death. Transgenic
mice devoid of PrPc are unable to sustain TSE infection
after experimental inoculation demonstrating the key role
of PrPc in the pathogenesis of these diseases [3].
The PrP gene is highly preserved among mammals [4],
and sequences of prion-like cDNAs have been described
in other vertebrate classes including birds [5-7], reptiles
[8,9], amphibians [10], and fish [11-13]. The presence of
proteins "similar to" PrPc (stPrP, [12]) in fish has raised
concern about a possible transmission of TSE agents to
humans through consumption of farmed fish since mam-
malian MBM (meat and bone meal) and other mamma-
lian products were historically fed to farmed fish [14]. The
distribution of stPrP in trout organism was also studied
through the use of newly described monoclonal antibod-
ies which show that the protein is preferentially distrib-
uted in brain, optic nerve and spinal cord in contrast to its
absence (or presence at undetectable level) outside the
nervous system, including the intestine [15].
The passage of TSE agents between animals of different
species is usually impaired by what is called the species
barrier, i.e. the difficulty to establish clinical disease into
the new host even after a prolonged incubation period.
Infectivity, however, might be present without clinical
presentation of disease, and tissues from first attempted
transmission might be infectious when re-inoculated in
susceptible animals [16].
The need to give an answer to public concern about safety
of food possibly contaminated with TSE agents prompted
us to set up an experiment that uses fish as recipient of a
scrapie agent (mouse-adapted 139A strain). Both "in
vitro" and "in vivo" approaches were devised in an
attempt to draw a pattern of risk related to human con-
sumption of fish products. The 139A mouse-adapted TSE
scrapie strain was chosen because of its ability to cross the
species barrier in different species of rodents [17], while
trout (Oncorhynchus mykiss) and turbot (Scophthalmus max-
imus) for their large use in aquaculture food industry. We
also challenged the "in vitro" ability of PrPSc to cross the
intestinal tissues of rainbow trout when 139A was added
to the mucosal side of everted or statically perfused intes-
tine.
Results and discussion
Our major aim was to investigate whether tissues of orally
infected fish would retain some residual infectivity (i.e.,
not due to replication of TSE agents). Thus, turbot and
trout were forced-fed with the 139A strain of scrapie and
sacrificed from 1 to 90 days after challenge. Muscle, intes-
tine, and brain were taken at different time points (1, 15,
30, 60 and 90 days post inoculation) and inoculated into
recipient mice for the measurement of residual infectivity
(Table 1A).
No behavioral or swimming abnormalities were observed
in orally inoculated trout and turbot and histological
examination of tissues from inoculated fish did not show
any pathological mark nor prion protein was detected by
immunohistochemical examination (data not shown).
None of the recipient mice developed scrapie disease. No
PrPSc was detected in the brain of the mice injected with
turbot tissues (Table 1A). However, PrPSc was detected in
the brain of one from the 8 mice inoculated with the intes-
tine of trout taken one day after force-feeding inoculation,
suggesting that the trout intestine contained some resid-
ual infectivity.
We therefore investigated whether trout intestine binds
PrPSc and transfers it to the serosal side where it may
spread to the lymphoid tissues and, eventually into the
CNS. Using everted trout intestine immersed in a solution
containing 139A we observed that PrPSc slightly absorbs to
the mucosal intestinal layer as shown by the low, yet
detectable signal at the western blot (Figure 1C). When
statically perfused intestine was used in order to study the
possible role of pyloric caeca in PrPSc absorption, it was
possible to detect the presence of PrPSc by immunohisto-
chemistry in the stratum compactum both in the trout intes-
tine and in the pyloric caeca (Figure 2c, 2f). On the other
hand, the absence of signal for PrPSc at the western blot in
the solution fluxed into the serosal side of the everted
intestine (Figure 1B) excludes, at least in this experimental
setting, an active secretion of PrPSc from one side to the
other side of the intestinal tract.
Such data are in agreement with the recent finding that
stPrP is not detectable in the intestine of Rainbow trout
[15], which renders unlikely an active uptake of exoge-
nous PrPSc, but does not exclude an unspecific binding of
PrPSc to the fish intestinal mucosa.Page 2 of 7
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with the same strain of scrapie as above by parenteral
routes to increase the possibility of a successful infection
(Table 1B). Brain and spleen, as the most likely tissues for
PrPSc accumulation, were taken 15 and 90 days (the long-
est survival time of fish in a close circuit water tanks) after
inoculation and residual infectivity was bio-assayed in
mice. None of the recipient mice developed scrapie dis-
ease during their lifespan. However, PrPSc was observed at
the western blot in the brain of a few recipient mice inoc-
ulated with tissues taken from turbot or trout (Table 1B).
These data show that 15 days after inoculation only about
one LD50 of scrapie-infectivity is present in the spleen of
turbot, and much less in the brain of turbot or in the
spleen of trout. Almost no infectivity (only 1 in 37 recipi-
ent mice were PrPSc positive) was however detected 90
days after inoculation of fish tissues, suggesting that the
infectivity measured at 15 days post inoculation was likely
related to the residual inoculum. As the fishes were not
kept more than 90 days, it is not possible to exclude that
infectivity might develop at a later time point, after an ini-
tial clearance phase of the inoculum, though this possibil-
ity is not likely.
In our work, we did not evaluate whether mammalian TSE
agents may establish infection in fish. Nonetheless, the
"lesion profile" curves based upon the severity of spongi-
form changes in brain areas of mice injected with 139A
before and after passage in fish (Figure 3), show a similar
pattern suggesting that the 139A strain did not adapt to
fish in the 3 months period examined. A statistical com-
parison of scores between the two curves, done area by
area by the Mann-Whitney's test, showed a significant dif-
ference only in the dorsal medulla area (p = 0.045). No
statistically significant difference was observed in the
superior colliculus, hypothalamus, cingulate, and adja-
cent cortices. Permutation tests performed to overcome
problems due to the small sample size, confirmed this
pattern. The overall lower scores observed in the brain of
mice inoculated with fish tissues could merely represent
the fact that these mice were not symptomatic when sacri-
ficed while control scrapie infected mice showed evident
clinical signs of disease.
Conclusion
These data show that about 4 million LD50 of 139A given
by forced feeding were readily removed from fish intestine
(both trout and turbot) in the first 24 hours after infection
and that infection never reached the brain, the spleen or
the muscles. This suggests that scrapie is quickly removed
from fish tissues despite the presence of a cellular prion-
like protein [15,18] and a prion protein-like gene in fish
[11-13]. With all the cautions due to the difference
between the 139A and the BSE strains, and that in this
experiment fishes were observed for no more than 90 days
after infection, it is tentatively possible to assume that the
consumption of fish fed with BSE-infected MBM should
not pose any substantial threat to public health.
Methods
"In vitro" experiments
Rainbow trout (Oncorhynchus mykiss) from 50 to 200 g of
body weight were kept at 15°C for one week and starved
24 hours before the experiments. After sacrifice with a
lethal dose of MS 222 (200 mg/l) the whole intestine was
extracted, carefully everted, and canulated according to
published procedures [19,20]. Briefly, canulated intestine
was submerged in 25 ml of physiological solution (145
Table 1: Measurement of scrapie infectivity in fish tissues by mouse bioassay. Brains from recipient mice inoculated with turbot or 
trout tissues from either oral or multiple parenteral routes were assayed for PrPSc by Western blot. Whenever samples were 
available, histology and/or immunohistochemistry was performed. Asterisks indicate mice contributing to the lesion profiles curve of 
the fish-passaged 139A (Figure 3)
A. Tissues from infected fish via the oral route
Turbot Trout
Days after infection Muscle Intestine Brain Spleen Muscle Intestine Brain Spleen
1 0/10 0/8 0/8 - 0/10 1/8 0/5 -
15 0/7 0/8 0/6 - 0/10 0/8 0/13 -
30 0/10 0/8 0/10 - 0/8 0/8 0/9 -
60 0/9 0/6 0/8 - 0/7 0/6 0/6 -
90 0/7 0/8 0/9 - 0/10 0/11 0/10 -
B. Tissues from infected fish via multiple parenteral routes
15 - - 2/8 4/7* - - 0/9 1/9*
90 - - 1/7* 0/8 - - 0/11 0/11Page 3 of 7
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CaCl2·2H2O, 10 mM NaHCO3, 5 mM D-Glucose, pH
7.2) containing scrapie mice brain homogenate (139A) to
a final concentration of 5 mg/ml under constant agitation
by air pump (sample A). The same solution, but without
infected brain material (sample B), was fluxed through
the canula inside the serosal side of the intestine by a per-
istaltic pump (1 ml/min) and collected for 1 h. After per-
fusion, the fish intestinal mucosa was abraded with a glass
blade, homogenized in PBS (1:4 vol/vol), and further ana-
lysed for PrPSc detection by Western blot (sample C). Aliq-
uots of 30 µl from samples A, B (sample B was lyophilised
and resuspended in 1% wt/vol sarcosyl solution), and C
were processed for PrPSc detection [21], using the mouse
monoclonal antibody SAF83 (1:10000). This antibody
was selected after screening different antibodies (SAF70,
SAF32, 6H4, 8G8, SAF83, SAF84) for their ability to detect
PrPSc on the fish mucosa homogenate. SAF70 and SAF84
showed cross reactivity with the fish mucosa, and 6H4
and 8G8 showed very low ability to detect PrPSc. On the
other hand, SAF32 and SAF83 were equally able to detect
PrPSc with no cross reactivity with the fish mucosa.
Trout gastrointestinal tract, from oesophagus to anus, was
submerged in sample A (see above) to be statically per-
fused. Samples were carefully washed and dissected in 10
mm segments. Cross sections, 1 mm thick, were randomly
excised from each segment of the gastrointestinal tract,
fixed in 0.8% glutharaldehyde, 3.0% formaldehyde in
0.01 phosphate buffer saline (PBS), dehydrated, embed-
ded in hydroxyethyl-methacrylate (Kulzer Histo-Technik
8100, Germany) and serially cut. For immunostaining,
sections were subjected to antigen retrieval (98% formic
acid for 15 min or alternatively to microwave pretreat-
ment at 600 W for 60 sec in PBS), before incubation with
the primary antibody SAF83 at different dilutions. After
incubation with a goat-anti mouse secondary antibody
conjugated with 6 nm colloidal gold, the slides were
rinsed and left to dry for one day before silver staining. Sil-
ver enhancement was performed with R-GENT kit for light
microscopy (Aurion, The Netherlands). All samples were
counterstained with 0.1% toluidine blue observed with
epifluorescence (excitation 520–550 nm).
"In vivo" experiment
Trout (Oncorhynchus mykiss) and turbots (Scophthalmus
maximus) of 8 cm length were obtained from a commer-
PrPSc detection in the mucosal solution (A), the serosal solution (B), and the scraped mucosal layer (C) of trout everted intes-tineFigure 1
PrPSc detection in the mucosal solution (A), the serosal solution (B), and the scraped mucosal layer (C) of 
trout everted intestine. Western blot analysis of PrPSc in the crude mice brain homogenate (positive control, +), in the 
diluted mice brain homogenate solution (1:20) perfonding the mucosal side of the trout everted intestine (A), in the physiolog-
ical solution fluxing the serosal side of the trout everted intestine (B), and in the scraped mucosal layer of the trout intestine 
(C). The mucosal tissue in sample C was obtained by gently washing (1 min) the intestine with a saline cold solution then 
ablated and homogenized 1 hour after perfusion (C). The experiment was repeated on three different trout intestine (1, 2, 3). 
The classical tri-banded pattern of diglycosylated, mono- and unglycosylated PrPSc was absent in B and only barely detectable in 
C suggesting a low absorption of PrPSc to the mucosal side of trout intestine and the absence of an active PrPSc transport 
through the intestinal barrier.Page 4 of 7
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weeks before oral or parenteral infection with the mouse-
adapted 139A strain of scrapie. The inoculum was pre-
pared from a pool of 70 g of 139A scrapie-infected mouse
(C57/BL) brains. Brain tissue was homogenized in sterile
PBS to obtain a 10% (wt/vol) suspension, centrifuged at
913 × g (4°C per 15 minutes), and supernatant collected.
Infectivity titre of this suspension was calculated by end-
point titration as previously described [22], using groups
of 6–10 animals for each dilution. The amount of infectiv-
ity, calculated by the Reed and Muench method, was 108.9
LD50 per gram of tissue. Control homogenate was pre-
pared with the same procedure using brain tissue from
healthy mice. One group of turbots (n = 20) or trout (n =
PrPSc accumulation in the pyloric caeca (a, b, c) and non-everted intestine (d, e, f) of trout intestine statically perfusedFigure 2
PrPSc accumulation in the pyloric caeca (a, b, c) and non-everted intestine (d, e, f) of trout intestine statically 
perfused. Immunohistochemistry on trout sections of pyloric caeca (a, b, c) and non-everted intestines (d, e, f). The static per-
fusion was performed for 1 hour at 15°C, in a PBS solution containing 50 µl/ml of either 10% uninfected mice brain homoge-
nate (a, d) or 10% mice scrapie brain homogenate (139A) (b, c, e, f). Immunolabelling was performed with the monoclonal 
antibody SAF83 (a, c, d, f), or, as control, the monoclonal anti-HA against influenza virus (anti-HA, clone 12CA5, subtype 
IgG2b, k), (b, e). All the immunogold-labelled sections were silver enhanced and counterstained with 0.1% toluidine blue (see 
materials and methods for details). PrPSc localisation (arrows) occurred in the stratum compactum (S) of distal intestine and 
pyloric caecum incubated with SAF83 (c, f). No immunolabelling was present in control tissues incubated with the same anti-
body (a, d), except for a low unspecific background. The background was slightly higher, though unspecific, in anti-HA labelled 
sections (b, e) due to the high reactivity of this antibody. All micrographs were taken at the same magnifications; V = villo, T = 
tunica muscolaris; asterisks point to unspecific labelling present in all samples and due to micro-fractures between the outer 
specimen surface and the resin.Page 5 of 7
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(106.6 LD50) or control mouse brain homogenates.
Another group of turbots (n = 30) or trout (n = 30) was
simultaneously inoculated by the intracerebral (0.03 ml,
106.4 LD50), intraperitoneal (0.1 ml, 106.9 LD50), and intra-
muscular (0.1 ml, 106.9 LD50) routes with either 139A or
control brain homogenates. After inoculation, fish were
maintained in close circuit water tanks under bio-security
conditions to avoid water contamination with the scrapie
agent.
Samples from brain, muscle, and intestine were taken
from 3 orally-infected and 1 control fish for each species
at 1, 15, 30, 60 and 90 days post-infection. Moreover,
brain and spleen were taken from parenterally infected
fish at 15 and 90 days post-infection. Collected samples
were divided in two parts: one was immediately frozen at
-80°C for measuring scrapie infectivity by mouse bio-
assay, the other was fixed for histological or immunohis-
tochemical examination. Histopathological examination
of fish tissues was routinely performed on every sample
collected. Briefly, samples were fixed in Davidson and
processed in an automatic tissue processor, embedded in
paraffin and cut in 5 µm sections, deparaffinized, rehy-
dratated and then stained with haematoxylin-eosin. The
immunohistochemical detection of the prion protein in
fish tissue sections was performed as described [23].
For the bioassay of fish tissues in mice, each group of fish
samples, belonging to the same time point, was homoge-
nized using separate sets of instruments to avoid acciden-
tal cross-contamination. Homogenisers were then
accurately decontaminated (2 cycles of autoclave at
134°C for 1 hour followed by extensive washing and a
third cycle of autoclave at 120°C for 20 minutes) before
re-use on another group of samples. Twenty µl of 10% tis-
sue homogenate were injected intracerebrally in groups of
6–11 C57/BL male mice for infectivity bioassay. Animals
showing clinical signs (not necessarily related to scrapie)
or moribund were sacrificed, their brains removed and
divided in two halves. One half was immediately frozen at
-70°C for PrPSc analysis, the other half was fixed in forma-
lin for histological examination. PrPSc was purified as
described [24] and detected by western blotting using
monoclonal antibody SAF84 (SpiBio) diluted 1:5000.
Mice were housed at the animal facility of the Istituto
Superiore di Sanità (ISS) under the supervision of the
Service for Biotechnology and Animal Welfare of the ISS
who warrants the adherence to the national and interna-
tional regulations on animal welfare.
Histological analysis and lesion profiles of mice brains
Formalin-fixed brains were decontaminated with 98%
formic acid for 1 h, stained with haematoxylin-eosin and
scored for the intensity of vacuolar degeneration (ranging
from 0, no vacuolar change, to 5, severe vacuolar change)
in nine standard grey matter areas for building up the
'lesion profiles' [25]. Sections were coded and blind exam-
ined. In Figure 3, the lesion profile of 139A after passage
in fish was a mean of 4 animals when brains for histology
were available (2 mice inoculated with turbot spleen at 15
days, 1 mouse inoculated with trout spleen at 15 days,
and 1 turbot brain taken 90 days after parenteral inocula-
tion). We pooled these data together because none of
these mice showed clinical signs and were sacrificed at
about the same time after inoculation (221, 204, 215, and
221 days, respectively). The reference curve of 139A not
passaged in fish was obtained pooling data from 6 mice.
Immunohistochemistry was performed as described [23].
Abbreviations
PrP: prion protein
PrPc: cellular prion protein
PrPSc: pathological prion protein
stPrP: "similar to" PrP
Lesion profiles for mice following inoculation with 139A b fore (circ ) and after (square) passage in fishFigure 3
Lesion profiles for mice following inoculation with 
139A before (circle) and after (square) passage in 
fish. The lesion profiles for the fish-passaged 139A (square) 
was a mean of 4 mice: 2 mice inoculated with turbot spleen 
at 15 days, 1 mouse inoculated with trout spleen at 15 days, 
and 1 turbot brain taken 90 days after parenteral inoculation. 
The reference curve (circle) was a mean of 6 mice inoculated 
with the 139A non passaged in fish. Vacuolation was evalu-
ated in nine standard areas: 1, dorsal medulla; 2, cerebellar 
cortex; 3, superior colliculus; 4, hypothalamus; 5, thalamus; 6, 
hippocampus; 7, septum; 8, retrosplenial and adjacent motor 
cortex; 9, cingulate and adjacent motor cortex. Data are 
mean ± SE.
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GSS: Gerstmann-Sträussler-Scheinker disease
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